Fig. 5

Cell viability of CBC3T-6 cells, CBC3T-1 cells, and TFK-1 cells after 48 h of exposure to anticancer drugs. a-c Dose‒response curves of CBC3T-6 cells, CBC3T-1 cells and TFK-1 cells treated with 5-FU, gemcitabine, cisplatin, paclitaxel, and oxaliplatin.